Wake-Up America: Why This Cannabis News Is A Game Changer
Portfolio Pulse from Todd Harrison
Cannabis stocks rallied after a leaked letter revealed that the U.S Department of Health and Human Services (HHS) recommended the Drug Enforcement Administration (DEA) reclassify cannabis from Schedule I to Schedule III under federal law. This move is seen as the most significant federal cannabis reform in modern history. The U.S canna ETF MSOS and Curaleaf (OTC:CURLF) are among the stocks that could benefit from this development.
September 01, 2023 | 2:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Curaleaf (OTC:CURLF) could benefit from the potential reclassification of cannabis. The company's chairman spoke on SAFE Banking and the massive short squeeze in play.
The potential reclassification of cannabis could lead to a surge in cannabis stocks, including Curaleaf. The company's chairman has spoken on the potential benefits of SAFE Banking and the massive short squeeze in play.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
The U.S canna ETF MSOS could see significant gains following the potential reclassification of cannabis. The ETF previously traded at $15 in December on the speculation that SAFE Banking would pass.
The potential reclassification of cannabis could lead to a surge in cannabis stocks, including the U.S canna ETF MSOS. The ETF previously saw a rise in its trading price due to speculation around the passing of SAFE Banking.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90